Paula Krakowiak

Summary

Affiliation: University of California
Country: USA

Publications

  1. pmc Maternal metabolic conditions and risk for autism and other neurodevelopmental disorders
    Paula Krakowiak
    Division of Epidemiology, Department of Public Health Sciences, University of California, Davis, California, USA
    Pediatrics 129:e1121-8. 2012
  2. doi request reprint Sleep problems in children with autism spectrum disorders, developmental delays, and typical development: a population-based study
    Paula Krakowiak
    Division of Epidemiology, Department of Public Health Sciences, School of Medicine, University of California, Davis, CA, USA
    J Sleep Res 17:197-206. 2008
  3. pmc Polybrominated diphenyl ethers in relation to autism and developmental delay: a case-control study
    Irva Hertz-Picciotto
    Department of Public Health Sciences, School of Medicine, University of California, MS1C, One Shields Ave, Davis, California, USA
    Environ Health 10:1. 2011
  4. pmc Elevated plasma cytokines in autism spectrum disorders provide evidence of immune dysfunction and are associated with impaired behavioral outcome
    Paul Ashwood
    Department of Medical Microbiology and Immunology, University of California, Davis, CA, USA
    Brain Behav Immun 25:40-5. 2011
  5. pmc Reduced levels of immunoglobulin in children with autism correlates with behavioral symptoms
    Luke Heuer
    Division of Rheumatology, Allergy and Clinical Immunology, University of California at Davis, Davis, California 95616, USA
    Autism Res 1:275-83. 2008
  6. doi request reprint Minor physical anomalies in children with autism spectrum disorders
    Kathleen Angkustsiri
    University of California, Davis, USA
    Autism 15:746-60. 2011
  7. doi request reprint Regression in autism: prevalence and associated factors in the CHARGE Study
    Robin L Hansen
    Medical Investigation of Neurodevelopmental Disorders Institute, University of California, Davis, Sacramento 95817, USA
    Ambul Pediatr 8:25-31. 2008
  8. pmc Increased IgG4 levels in children with autism disorder
    Amanda Enstrom
    Department of Medical Microbiology and Immunology, 2805, 50th Street, Wet Lab Building, Sacramento, CA 95817, USA
    Brain Behav Immun 23:389-95. 2009

Collaborators

Detail Information

Publications8

  1. pmc Maternal metabolic conditions and risk for autism and other neurodevelopmental disorders
    Paula Krakowiak
    Division of Epidemiology, Department of Public Health Sciences, University of California, Davis, California, USA
    Pediatrics 129:e1121-8. 2012
    ....
  2. doi request reprint Sleep problems in children with autism spectrum disorders, developmental delays, and typical development: a population-based study
    Paula Krakowiak
    Division of Epidemiology, Department of Public Health Sciences, School of Medicine, University of California, Davis, CA, USA
    J Sleep Res 17:197-206. 2008
    ..Factor scores for children with DD were intermediate between the ASD and TD groups. Cognitive or adaptive development did not predict severity of sleep problems in the ASD group...
  3. pmc Polybrominated diphenyl ethers in relation to autism and developmental delay: a case-control study
    Irva Hertz-Picciotto
    Department of Public Health Sciences, School of Medicine, University of California, MS1C, One Shields Ave, Davis, California, USA
    Environ Health 10:1. 2011
    ..PBDEs and their metabolites cross the placenta and studies in rodents demonstrate neurodevelopmental toxicity from prenatal exposures. PBDE exposures occur both via breastfeeding and hand-to-mouth activities in small children...
  4. pmc Elevated plasma cytokines in autism spectrum disorders provide evidence of immune dysfunction and are associated with impaired behavioral outcome
    Paul Ashwood
    Department of Medical Microbiology and Immunology, University of California, Davis, CA, USA
    Brain Behav Immun 25:40-5. 2011
    ..The characterization of immunological parameters in ASD has important implications for diagnosis, and should be considered when designing therapeutic strategies to treat core symptoms and behavioral impairments of ASD...
  5. pmc Reduced levels of immunoglobulin in children with autism correlates with behavioral symptoms
    Luke Heuer
    Division of Rheumatology, Allergy and Clinical Immunology, University of California at Davis, Davis, California 95616, USA
    Autism Res 1:275-83. 2008
    ..To assay if plasma antibody levels in children with autism or developmental delays (DD) differ from those with typical development as an indicator of immune function and to correlate antibody levels with severity of behavioral symptoms...
  6. doi request reprint Minor physical anomalies in children with autism spectrum disorders
    Kathleen Angkustsiri
    University of California, Davis, USA
    Autism 15:746-60. 2011
    ..This study employs an adaptation of Miles and Hillman's (2000) classifications by using photographs to identify a subgroup with significant dysmorphology among children with ASD, typical development (TYP), and developmental delay (DD)...
  7. doi request reprint Regression in autism: prevalence and associated factors in the CHARGE Study
    Robin L Hansen
    Medical Investigation of Neurodevelopmental Disorders Institute, University of California, Davis, Sacramento 95817, USA
    Ambul Pediatr 8:25-31. 2008
    ..The aim of this study was to examine the prevalence of regressive autism and associated demographic, medical, and developmental factors by using 2 different definitions of regression based on the Autism Diagnostic Interview, Revised...
  8. pmc Increased IgG4 levels in children with autism disorder
    Amanda Enstrom
    Department of Medical Microbiology and Immunology, 2805, 50th Street, Wet Lab Building, Sacramento, CA 95817, USA
    Brain Behav Immun 23:389-95. 2009
    ..Further investigation is necessary to elucidate the relationship between immunological findings and behavioral impairments in autism...